Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited.

Trends in cardiovascular medicine - 1 Nov 2007

Eickelberg Oliver, Morty Rory E

Abstract excerpt

Growth factors of the transforming growth factor (TGF) beta superfamily have emerged as important regulators of normal cardiovascular development, as well as modulators of the onset or progression of vascular diseases. Recently, familial and idiopathic pulmonary arterial hypertension (IPAH) has been causally linked to somatic and genetic perturbations to the TGF-beta/bone morphogenic protein (BMP) system,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Morphogenetic Protein Receptors, Type II
Share to Bone Morphogenetic Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Endothelium

Share to Hypertension, Pulmonary

Share to Muscle, Smooth

Share to Signal Transduction

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 18021936
DOI: 10.1016/j.tcm.2007.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited.PMID 18021936Read ↗

Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?Semantic proximity Read ↗

Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.Semantic proximity Read ↗

Recent insights into the pathogenesis and therapeutics of pulmonary hypertension.Semantic proximity Read ↗

[Pulmonary hypertension: pathophysiology, genetics and functional genomics].Semantic proximity Read ↗

TGF-β and BMPR-II pharmacology—implications for pulmonary vascular diseasesSemantic proximity Read ↗

TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One FamilySemantic proximity Read ↗

Significance of BMPR2 mutations in pulmonary arterial hypertension.Semantic proximity Read ↗

Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies.Semantic proximity Read ↗

Transforming growth factor-betas and vascular disorders.Semantic proximity Read ↗

Targeting transforming growth factor-β receptors in pulmonary hypertensionSemantic proximity Read ↗

Cross talk between Smad, MAPK, and actin in the etiology of pulmonary arterial hypertension.Semantic proximity Read ↗

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.